John Gill is Director of Altimmune, Inc.. Currently has a direct ownership of 2,771 shares of ALT, which is worth approximately $18,233. The most recent transaction as insider was on Aug 12, 2022, when has been sold 2,714 shares (Common Stock, par value $0.0001) at a price of $15.0 per share, resulting in proceeds of $40,710. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.77K
0% 3M change
0% 12M change
Total Value Held $18,233

JOHN GILL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2022
SELL
Open market or private sale
$40,710 $15.0 p/Share
2,714 Reduced 49.48%
2,771 Common Stock, par valu...
Nov 30 2020
SELL
Open market or private sale
$100,426 $11.92 p/Share
8,425 Reduced 42.93%
11,199 Common Stock, par valu...
Sep 24 2020
BUY
Exercise of conversion of derivative security
-
16,850 Added 46.2%
19,624 Common Stock, par valu...
JG

John Gill

Director
Gaithersburg, MD

Track Institutional and Insider Activities on ALT

Follow Altimmune, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALT shares.

Notify only if

Insider Trading

Get notified when an Altimmune, Inc. insider buys or sells ALT shares.

Notify only if

News

Receive news related to Altimmune, Inc.

Track Activities on ALT